-
Subject Areas on Research
-
A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study).
-
A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military Veterans resistant to antidepressant treatment.
-
A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP).
-
A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophrenia.
-
A repeated measures model for analysis of continuous outcomes in sequential parallel comparison design studies.
-
A retrospective study exploring the effects of intramuscular aripiprazole on QTc change in agitated medically ill patients.
-
Advances in Pharmacotherapy of Late-Life Depression.
-
An open-label pilot study of aripiprazole for male and female veterans with chronic post-traumatic stress disorder who respond suboptimally to antidepressants.
-
Aripiprazole for agitation in a 13-year-old girl with neuroleptic malignant syndrome.
-
Aripiprazole: pharmacology, efficacy, safety and tolerability.
-
Atypical antipsychotics and pituitary tumors: a pharmacovigilance study.
-
Changes in weight and weight-related quality of life in a multicentre, randomized trial of aripiprazole versus standard of care.
-
Comparison of academic and nonacademic sites in multi-center clinical trials.
-
Deletion of GSK3β in D2R-expressing neurons reveals distinct roles for β-arrestin signaling in antipsychotic and lithium action.
-
Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: results from a randomized controlled trial.
-
Efficacy and safety of adjunctive aripiprazole in major depressive disorder in older patients: a pooled subpopulation analysis.
-
Efficacy of dose increase among nonresponders to low-dose aripiprazole augmentation in patients with inadequate response to antidepressant treatment: a randomized, double-blind, placebo-controlled, efficacy trial.
-
Implications of atypical antipsychotic prescribing in the intensive care unit.
-
Results of phase 3 of the CATIE schizophrenia trial.
-
Structure-functional selectivity relationship studies of β-arrestin-biased dopamine Dâ‚‚ receptor agonists.
-
The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update.
-
The effects of aripiprazole on the subscales of the Kellner Symptom Questionnaire in treatment resistant depression.
-
The use of aripiprazole in obsessive-compulsive disorder: preliminary observations in 8 patients.
-
Use of aripiprazole in a patient with multiple sclerosis presenting with paranoid psychosis.